Sign In

Dr. Alexander Breidenbach

Chief Business Officer at Pharming Group N.V.

Dr. Alexander Breidenbach is the Chief Business Officer (CBO) at Pharming Group N.V., a position he assumed on September 1, 2023. He is also a member of the Executive Committee at the company.14 With over 20 years of experience in the pharmaceutical industry, Dr. Breidenbach has extensive expertise in research and development, management, and business partnerships.2

In addition to his role at Pharming, he serves as the Chief Financial Officer (CFO) of Sensorion, a gene therapy company listed on Euronext Growth in Paris, and holds a directorship at EnteroBiotix Ltd..3 His career reflects a strong focus on drug development and business strategy within the biotech sector.

Highlights

Feb 29 · linkedin

Exciting opportunity to join a dynamic team! Pharming, a pure play rare disease company, will further grow by expanding its pipeline via partnering with pharma and biotech.

https://lnkd.in/etDGurCi

Jun 3 · linkedin

It is with great excitement that ACM Biolabs will present its Phase I data to our partners at BIO 2023. Our Tunable Platform (ATP™) is clinically validated and we are looking forward to meeting you who share our vision to accelerate development of programs for the benefit of patients in need!

Related Questions

What are Dr. Alexander Breidenbach's key achievements in the pharmaceutical industry?
How did Dr. Alexander Breidenbach transition from CFO of Sensorion to CBO at Pharming Group N.V?
What are Dr. Alexander Breidenbach's main responsibilities as Chief Business Officer at Pharming Group N.V?
What companies has Dr. Alexander Breidenbach worked for before joining Pharming Group N.V?
What are Dr. Alexander Breidenbach's thoughts on future trends in the pharmaceutical industry?
Dr. Alexander Breidenbach
Dr. Alexander Breidenbach, photo 1
Dr. Alexander Breidenbach, photo 2
Add to my network

Location

Netherlands